Vimarsana
Biggest News Aggregation in the World

While Astrazeneca News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from While Astrazeneca. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In While Astrazeneca Today - Breaking & Trending Today

GSK's revenues top £30bn as vaccine and cancer drug sales soar - Vimarsana News

GSK's revenues top £30bn as vaccine and cancer drug sales soar

GSK's annual vaccine sales surged by 25%, driven by Shingrix and Arexvy. Cancer drugs also performed strongly.

The Public Health Emergency Expiring, So What Is the Future of Covid-19 Vaccines? - Vimarsana News

The Public Health Emergency Expiring, So What Is the Future of Covid-19 Vaccines?

The FDA will decide this summer which strains the next Covid-19 vaccines should address. But companies are also taking a longer view, developing shots for the future that offer different features than the current ones and potentially broader protection against a wider range of pathogens.

BUSINESS LIVE: Unilever lifted by price hikes; AZ sales miss forecasts - Vimarsana News

BUSINESS LIVE: Unilever lifted by price hikes; AZ sales miss forecasts

Among the companies with reports and trading updates today are Unilever, British American Tobacco, AstraZeneca, Bellway, Compass Group and Redrow.

Top 8 Best-Selling COVID-19 Vaccines and Drugs of Q1 2021 - Vimarsana News

Top 8 Best-Selling COVID-19 Vaccines and Drugs of Q1 2021

The first authorized drugs and vaccines indicated for COVID-19 generated more than a combined $10.91 billion in sales during the first quarter of 2021—more than double the $4.23 billion generated all of 2020. This list contains the Top 8 Best-Selling COVID-19 Vaccines and Drugs of Q1 2021

AstraZeneca booster OK, says paper; Serum Institute seeks nod - Vimarsana News

AstraZeneca booster OK, says paper; Serum Institute seeks nod

But while all the seven vaccines boosted spike protein immunogenicity after two doses of AstraZeneca, in case of Pfizer, after two doses, a booster dose of Valneva was not found to be effective.

Related Topics:
While Astrazeneca